Delve newsletter · Issue 5 · Sales review
Sudhir Sharma, founder, Delve Solutions · 14 November 2026 · 6 minutes
Ask a medical representative what happens in the monthly review and he can recite it before the meeting starts.
Call average. Doctor coverage. Sales against target. A word about working harder. Next person.
Ask the manager, and the answer is not very different. He has run the same meeting for years. The slides change their month and nothing else.
That is why so many people in the field see no value in the review. Not because they fear it. Because it is the same every time, and it never tells them anything they did not already know.
The review is stuck at one point: the numbers are read out, but they are never joined to each other.
Look at what is usually on the table.
They sit on two different slides, and the meeting moves from one to the other without asking how they are connected. So you get two conversations that go nowhere.
The rep with good calls and poor sales is told to improve his sales. He already knows that. Nobody tells him which doctors, which brand or which stockist.
The rep with poor calls and good sales is told to improve his calls. He smiles. His sales are fine, so he has just learnt that the call numbers do not matter.
In both cases the review has stated the result and stopped. "Sales are down eight per cent" is not a finding. It is the question.
1. The numbers are totals.
A total hides the place where the problem is. A territory at ninety per cent of target can be nine healthy stockists and one that has stopped buying, or it can be every stockist a little short. Those are two different problems with two different answers, and the total looks the same.
2. The review looks at one month.
A single month says how much. Only several months together say what is changing. A doctor missed once is a busy week. A doctor missed four months in a row is a decision somebody made, and never said aloud.
3. Activity and outcome are never put side by side.
Coverage is counted, and sales are counted, but nobody asks: of the doctors we met, which ones is the chemist actually selling for? Which brand did we talk about, and which brand moved? Until the two are on one page, the call report and the sales sheet are two separate stories.
So the manager falls back on the only advice a total allows: more calls, more effort. The rep hears it every month. That is the monotony.
A review earns its time when it moves from how much to where and why. These five questions do that.
1. Is the sale real, or is it sitting at the stockist?
Compare what the company billed with what the stockist sold onward. Primary running well ahead of secondary is not a good month; it is next month's problem, already booked.
2. Which place, exactly?
Not the region and not the team. Which headquarters, which stockist, which product. A review that cannot name the place cannot fix it.
3. Since when?
One bad month and three falling months need different conversations. Ask for the trend before the explanation.
4. Which doctors are we not meeting, month after month?
Coverage of ninety per cent says nothing about the ten per cent, and it is usually the same ten per cent every month.
5. Are we talking about the brand that is moving?
Put the chemist audit beside the detailing. A brand that the doctor's chemist sells and the rep never detailed is an open door. A brand detailed in every call that does not move at the chemist is a different lesson.
When the review answers these, the conversation changes by itself. It is no longer "your sales are down". It is "this stockist is carrying two months of stock, and these six doctors have not been met since August". That is something a person can act on.
You can begin with your next review, with or without any software:
Sarahana means appreciation. A review can end there only if it has first found something true to talk about. Delve-Sarahana Review is built to point at the place, so the meeting can start from it.
The system does not decide why. It shows where to look, with the number that sent you there. The why is still the manager's work, and it is the part of the review worth holding a meeting for.
Next Thursday: finding the issue is half the review. The other half is what happens after the meeting: who does what, by when, and what became of it at the next review.
One question for every manager reading this: in your last review, did anyone leave knowing something they did not know when they came in?
One practical idea a week on running a pharma field force, Delve-Gurukul training and mentoring, and the Delve Partner Program. Free. Every mail has an unsubscribe link.
Subscribe freeAlready subscribed and want to stop? Use the unsubscribe link at the foot of any newsletter mail, or write to helpdesk@delvesolutions.in.